Clinical Trial: A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269301) titled 'A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function' on Nov. 25.

Brief Summary: The purpose of this study is to understand the effects of decreased liver function on the study medicine (PF-07328948). People with decreased liver function may process the study medicine differently from healthy people.

We are seeking participants who:

* Are between 18 and 75 years of age.

* Have a BMI (body mass index) of 17.5 to 40 kg/m2, inclusive, and a total body weight of more than or equal to 45 kilograms or 99 pounds.

Participants will take the study medicine as a tablet onc...